U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07374692) titled 'Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors' on Jan. 28.
Brief Summary: Background:
Primary central nervous system (CNS) tumors grow in the brain and spinal cord. These tumors are rare, but they are difficult to treat and often fatal. SmartMatch is a new technology that tries to help find the best medicines for the particular tumor by testing how small pieces of surgically removed tumor tissue react to different drugs. The study team wants to see if SmartMatch can complete the analysis and generate a report within 21 days from the time of the surgery.
Objective:
To better underst...